With Israel as partner, Africa can turn cannabis into an economic game changer

Africa is asserting itself as a high-potential emerging region for large-scale cannabis grow operations. With South Africa leading the continent’s entry into the market along with the Kingdom of Lesotho and Zimbabwe, savvy investors are jockeying for position. But the future health of the African cannabis industry faces several challenges: maintaining consistent, sustainable product quality, overcoming regulatory uncertainty and promoting social justice are long-term considerations that should inform current decisions.


Israel is making all of the right moves to become a global cannabis hub

Read entire article here.

During the last few months, we have been highly focused on the Israeli medical cannabis opportunity and this is a market that we have been excited about. The country has been slow to issue cannabis businesses licenses and we are favorable on the companies that have a first-mover advantage on this market.


Israel: Government throws its weight behind medical cannabis sector

With the issuance of a wide-ranging ministry report on the medical cannabis industry, Israel is for the first time making clear its intention to back the burgeoning sector, according to a ministry official.

The white paper on Israel’s Medical Cannabis Innovation, published earlier this month, maps out the industry’s ecosystem — the key players, leading startups, breakthrough research at academic institutions, government regulations, and opportunities that await investors should they decide to take the plunge.


Israel: Investment in security for medical cannabis is on the rise

Globally, a preference for medical cannabis on the market has increased over the last few years, even in places where generalized use and sale of cannabis has been legalized. This trend has continued as the more and more consumers recognize the merits of medical cannabis increases, especially when compared to unregulated crops.

However, adhering to regulations all the way down the line – from the grower to the consumer – also requires increased investment in security measures.


Israel’s medical cannabis reform continues to benefit nearly no one

Israel’s medical cannabis patients are making another step in their battle against the country’s new regulation, which came into full effect in early September. Intended to help standardize the industry by requiring more stringent quality control and adding pharmacies as middlemen between growers and patients, the reform has so far resulted in market shortages and hiked prices. Now patients are demanding that pharmacies hand all their unstandardized supply back to the growers.


The scientist who identified THC is now working on synthetic cannabinoids

In the 55 years since he first isolated D9-tetrahydrocannabinol (better known today as THC) with colleagues Dr. Yehiel Gaoni and Dr. Haviv Edery at Israel’s Weizmann Institute of Science, Dr. Raphael Mechoulam has been the absolute leader in the science of cannabis. He basically started that science from scratch with 5 kilos of Lebanese hash the police donated to his research after Mechoulam’s boss put in the request.

Even all these years later, when Mechoulam talks pot, the cannabis world stops with its ears wide open. This latest announcement from the legendary scientist was no different.


‘The Father of Cannabis Research’ recognized with Lifetime Achievement Award and $10,000 grant

Raphael Mechoulam has spent a lifetime studying cannabis—now he’ll receive the highest of honours for his work.

The Arcview Group will celebrate the cannabis king with a Lifetime Achievement Award and a $10,000 research grant in its first annual cannabis awards presentation at the Arcview Investor Forum on Oct. 3.

“Raphael Mechoulam’s contribution to our understanding and ability to use the cannabis plant for positive benefits is immeasurable,” read a release from Arcview.


First cannabis-friendly cafe opens in Israel

Israel's first "coffeeshop" that allows medical marijuana users to smoke inside opened last week in the southern city of Beersheba, Mako reported on Thursday.
The shop opened in Beersheba on Thursday, making Israel the first Middle Eastern state with a specialized cannabis-consumption establishment.​

Top Israeli marijuana Firm to be bought out as owner faces legal battle

Medical marijuana company Cannabit is slated to buy out competitor Tikun Olam, after the two firms signed principles of agreement, which were revealed on Monday. Cannabit saw its valuation jump 13%, to 271 million shekels ($76.4 million), on the news.

Tikun Olam, in comparison, is one of Israel’s biggest, most respected medical marijuana companies, with some 15,000 customers and a well-regarded product. Patients view Tikun Olam’s cannabis strains as particularly high quality, according to interviews.


Israel to triple medical cannabis production

The Israeli government has reportedly issued seven new medical cannabis cultivation licences in a move that will triple the country’s annual production capacity.

Brlev Agricultural Crops, Elpis Flora, Medical Cannabis Growing, Natali Buskila, Rami Sela, S. Sydan and Shavit Agro are the seven firms given the green light to commence cultivation. They will be able to supply pharmacies across the country by the end of 2019, according to local reports.

The Israeli medicinal cannabis industry will be overhauled on Sunday, when new regulations come into effect. The idea is to stop marijuana produces selling direct to patients, requiring them to supply pharmacies that serve as middlemen instead.


Subscribe to RSS - Israel